Cite
HARVARD Citation
Belli, M. et al. (n.d.). Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry. Physica medica. pp. S23-S24. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belli, M. et al. (n.d.). Targeted alpha PSMA-based therapy of metastatic castrate-resistant prostate-cancer patients (mCRPC): prediction dosimetry. Physica medica. pp. S23-S24. [Online].